6bdb64ea-72f8-428a-920f-9f856b2e3db6.jpeg
These are questions i have to study for my exam can you teach me one by one as i go?
Reading File
analyse_media
Asking for Preferences
Which topic do you want to start with?
Finding Sources
Searching PubMed
"heart failure"[MeSH Terms] AND "drug therapy"[Subheading]
Searching the Web
heart failure guideline 2022 AHA/ACC/HFSA four pillars GDMT HFrEF classification stages
Reading File
Reading File
Essay 1: Heart Failure
I've started with the first topic on your list. The structure below works as an answer template.
1. Definition
Heart failure (HF) is a clinical syndrome in which the heart can't meet the metabolic needs of the body at normal filling pressures. It can come from systolic dysfunction or diastolic dysfunction. Fluid retention and pulmonary congestion are typical but not always present. That is why "heart failure" is preferred over "congestive heart failure" (Textbook of Family Medicine 9e, Heart Failure chapter).
2. Classification (write at least 3 of these)
| Basis | Types |
|---|---|
| Ejection fraction (EF) | HFrEF (EF ≤40%), HFmrEF (41-49%), HFpEF (≥50% with raised filling pressures), HFimpEF (previously ≤40%, now >40%) |
| Side | Left, right, biventricular |
| Course | Acute or chronic (acute decompensated) |
| Output | Low output (most causes) or high output (anemia, thyrotoxicosis, AV fistula, beriberi, Paget's disease) |
| ACC/AHA stage | A: at risk, no structural disease. B: structural disease, no symptoms (pre-HF). C: structural disease with symptoms. D: advanced, refractory HF |
| NYHA class | I: no limitation. II: symptoms on ordinary activity. III: symptoms on less than ordinary activity. IV: symptoms at rest |
The EF cut-offs and stages are from the 2022 ACC/AHA/HFSA guideline, as summarised by HFSA.
3. Etiology
- Systolic (HFrEF): ischemic heart disease (the commonest cause, which links to your Essay 4), dilated cardiomyopathy, myocarditis, and alcohol or drug toxicity (for example doxorubicin).
- Pressure overload: hypertension, aortic stenosis, coarctation.
- Volume overload: MR, AR, VSD, PDA.
- Diastolic (HFpEF): hypertension with LVH, hypertrophic or restrictive cardiomyopathy, constrictive pericarditis, ageing, diabetes.
- Right HF: left HF (commonest), cor pulmonale (COPD, pulmonary embolism, pulmonary hypertension), pulmonary stenosis, tricuspid disease.
- High output: anemia, thyrotoxicosis, beriberi, AV fistula.
Precipitating factors (a frequent exam point):
- Infection
- Arrhythmia (AF)
- Anemia
- Uncontrolled hypertension
- Fresh MI or ischemia
- Pulmonary embolism
- Drugs stopped or taken (NSAIDs, negative inotropes)
- Salt and fluid overload
- Pregnancy
- Thyrotoxicosis
- Infective endocarditis
4. Pathophysiology
The old hemodynamic model has been replaced by the neurohormonal and LV remodeling model. Whatever the initial injury (MI, hypertension, valve disease), the following happens:
- Cardiac output falls, so there is RAAS and sympathetic activation. Endothelin-1, vasopressin and inflammatory cytokines also rise.
- These are initially compensatory: they raise heart rate and contractility, cause salt and water retention, and cause vasoconstriction.
- They become harmful over time. Angiotensin II and aldosterone cause myocyte apoptosis, hypertrophy and fibrosis. Catecholamines are directly toxic and downregulate β-receptors. Afterload and preload both rise.
- The result is adverse remodeling: the ventricle dilates and stretches, and function falls further. This is a vicious cycle.
- This is why drugs that block neurohormones reduce mortality (Textbook of Family Medicine 9e). Aldosterone "escapes" ACE inhibition, so an MRA is needed as well.
Frank-Starling and ventricular hypertrophy are other compensatory mechanisms. They fail eventually.
5. Clinical features
Left HF (pulmonary congestion and low output):
- Exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea (PND)
- Cough with frothy or pink sputum
- Fatigue and weakness
- Signs: tachycardia, S3 gallop, pulsus alternans, displaced apex, basal crepitations, wheeze ("cardiac asthma"), pleural effusion
Right HF (systemic congestion):
- Raised JVP, tender hepatomegaly, ascites
- Pitting pedal edema, anasarca
- Anorexia and nausea from gut edema
- Signs: functional TR, parasternal heave
Cheyne-Stokes breathing and cardiac cachexia can occur in advanced HF.
Framingham criteria: diagnosis needs 2 major criteria, or 1 major plus 2 minor.
- Major: PND, neck vein distension, rales, cardiomegaly, acute pulmonary edema, S3, raised venous pressure, hepatojugular reflux, weight loss >4.5 kg on treatment.
- Minor: ankle edema, night cough, exertional dyspnea, hepatomegaly, pleural effusion, tachycardia >120/min.
6. Investigations
- Blood tests: BNP or NT-proBNP (raised; a normal value effectively rules out HF), CBC, renal function and electrolytes, LFTs, TSH, glucose, iron studies, troponin.
- ECG: may show MI, LVH, AF, LBBB, or low voltage.
- Chest X-ray: cardiomegaly (cardiothoracic ratio >0.5), upper lobe diversion, Kerley B lines, bat-wing perihilar haze, pleural effusion.
- Echocardiography (the key test): EF, chamber size, wall motion, valves, diastolic function, pericardium, pulmonary artery pressure.
- Others: coronary angiography or stress test for ischemia, cardiac MRI for cardiomyopathy or myocarditis, right heart catheterization in selected cases.
7. Management
Principles: treat the cause and precipitants, relieve symptoms, slow remodeling, and reduce mortality and hospitalization.
A. General measures
- Salt restriction and fluid restriction in severe HF
- Daily weights
- Stop smoking and alcohol
- Vaccination (influenza, pneumococcus)
- Exercise and cardiac rehabilitation
- Treat anemia and iron deficiency
- Avoid NSAIDs, non-DHP calcium channel blockers (verapamil, diltiazem) and thiazolidinediones
B. Chronic HFrEF: the "four pillars" of GDMT
All four are started as tolerated and titrated to target dose (2022 ACC/AHA/HFSA guideline summary):
| Drug class | Examples | Notes |
|---|---|---|
| ARNI (preferred), or ACEI/ARB | Sacubitril-valsartan; enalapril, ramipril; losartan, valsartan | Watch potassium, creatinine and hypotension. Don't combine an ACEI with an ARNI (36-hour gap). |
| Beta blocker | Carvedilol, bisoprolol, metoprolol succinate | Start low and go slow, once euvolemic. Never start in acute decompensation. |
| MRA | Spironolactone, eplerenone | Monitor potassium (<5.0) and creatinine. Gynecomastia with spironolactone. |
| SGLT2 inhibitor | Dapagliflozin, empagliflozin | Works with or without diabetes. |
Add-ons:
- Loop diuretics (furosemide) for symptom relief in fluid overload. They have no mortality benefit.
- Ivabradine if sinus rhythm with heart rate ≥70 on maximal beta blocker.
- Hydralazine plus isosorbide dinitrate if ACEI/ARB/ARNI is not tolerated, and in self-identified Black patients.
- Digoxin for symptoms or rate control in AF.
- Vericiguat in worsening HF.
- Iron (IV ferric carboxymaltose) if iron deficient.
- Anticoagulation for AF or LV thrombus.
C. Device therapy
- ICD for EF ≤35% despite 3 months of optimal therapy.
- CRT for EF ≤35%, LBBB and QRS ≥150 ms.
- LVAD or transplant for stage D.
D. HFpEF: treat hypertension, AF and obesity. Use diuretics for congestion. Give an SGLT2 inhibitor. An MRA or ARNI may help in selected patients.
E. Acute decompensated HF
- Sit the patient upright and give oxygen if SpO2 is <90%. Use CPAP or NIV if needed.
- IV loop diuretic (furosemide).
- IV nitrates if blood pressure is adequate.
- Opioids are not routine.
- Inotropes (dobutamine) or vasopressors in cardiogenic shock.
- Treat the precipitant.
8. Complications
- Arrhythmias and sudden cardiac death
- Thromboembolism
- Cardiorenal syndrome
- Cardiac cachexia
- Pleural effusion
- Cardiac cirrhosis
- Pump failure and cardiogenic shock
Five-year mortality after diagnosis is about 50% (Textbook of Family Medicine 9e).
9. Recent evidence check
A PubMed search for recent systematic reviews found a 2025 network meta-analysis in JACC on HFrEF drug therapy and a 2024 network meta-analysis on HFpEF. I only saw their titles and not their results, so I can't say what they conclude. The multi-drug approach above matches the guideline summary I found.
Quick recall for the exam
Mnemonic for the four pillars: "ABMS"
- ARNI/ACEI
- Beta blocker
- MRA
- SGLT2 inhibitor
Diuretics treat symptoms. The four pillars reduce death.
Next topic? A good order is:
- Topic 4 (HF due to CAD) and Topic 10 (pulmonary edema), since both build on what you just read.
- Topic 5 (heart attack), which is your most starred topic.
Tell me which one you want, or say "next" and I'll take 2 (tachyarrhythmias with AF). If you want, I can also quiz you on heart failure first.
This is a shared conversation. Sign in to Orris to start your own chat.